RESOURCES CITATIONS +
OVERCOMING LONG HAUL & CHRONIC FATIGUE SYNDROME SUMMIT
EXPERT SPEAKER
INTERVIEW RESOURCES
DR. GARY KAPLAN
Stu y g /3 of people may have Long Haul
COVID
Low-dose naltrexone paper may treat long COVID
Small study about COVID deaths due to glutathione deficiency
Mount Sinai study on Lack of Sleep with effects on the immune system
DR. JILL CRISTA
Aflatoxin increasing viral replication
Plaintain (RSV)
Red Clover (anti-pox, anti-SARS)
Red Clover (anti-coag)
Cleavers (anti-viral anthraquinone)
Cleavers (lymphatic/scavenging MOA)
Nettles (histamine block)
Nettles (reduction of mast cell degranulation)
DR. PAUL ANDERSON
Gastrointestinal post-acute COVID-19 syndrome
Viral Coinfection among COVID-19 Patient Groups
Is There a Connection Between Gut Microbiome
Dysbiosis Occurring in COVID-19 Patients and PostCOVID-19 Symptoms?
Small Intestinal Bacterial Overgrowth After COVID-19 Infection
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
COVID-19 and mycoplasma pneumoniae coinfection
Acute respiratory distress syndrome due to SARS-CoV2 and Influenza A co-infection in an Italian patient
COVID-19 Associated Pulmonary Aspergillosis (CAPA)
COVID-19-Associated Invasive Aspergillosis
The microbial coinfection in COVID-19
The Severity of the Co-infection of Mycoplasma pneumoniae in COVID-19 Patients
Post-COVID-19 functional gastrointestinal disorders: Prepare for a GI aftershock
Bacterial and fungal coinfection among hospitalized patients with COVID-19
DR. PAUL ANDERSON
CONTINUED
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARSCoV-2 agents
Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA)
Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity
Gastrointestinal post-acute COVID-19 syndrome
Bacterial co-infections with SARS-CoV-2
Reactivation of EBV and CMV in Severe COVID-19Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients
DR. PAUL ANDERSON
CONTINUED
The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection
SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea
COVID-19 Patients Need to Be Tested for Bacteria and Fungi, Not Just the Coronavirus
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU
Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline
High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19
[Reactivation of Epstein-Barr virus ( Herpesviridae: Lymphocryptovirus, HHV-4) infection during COVID19: epidemiological features]
DR. PAUL ANDERSON
CONTINUED
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Potential Associations Between Microbiome and COVID-19
Nutritional Modulation of Gut Microbiota Alleviates
Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome
Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes
Bacterial Coinfections in Coronavirus Disease 2019
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Co-infection with respiratory pathogens among COVID-2019 cases
DR. ISAAC ELIAZ
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Galectin-3 as a Potential Prognostic Biomarker for COVID-19 Disease: A Case-Control Study
Role of galectin-3 in autoimmune and nonautoimmune nephropathies
Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens
Potential Roles of Modified Pectin Targeting Galectin-3 against Severe Acute Respiratory Syndrome Coronavirus-2
Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway
Modified Citrus Pectin Prevents Blood-Brain Barrier
Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3
Pharmacological Inhibition of Galectin-3 Ameliorates
Diabetes-Associated Cognitive Impairment, Oxidative
Stress and Neuroinflammation in vivo and in vitro
DR. PIERRE KORY
FLCCC Education on Demand
FLCCC Long COVID Treatment
DR. BETH O'HARA
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence
Pathophysiology of Post-COVID syndromes: a new perspective
Mast cell activation symptoms are prevalent in LongCOVID
Connecting the Dots in Emerging Mast Cell Research: Do Factors Affecting Mast Cell Activation Provide a Missing Link between Adverse COVID-19 Outcomes and the Social Determinants of Health?
Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease
Restless legs syndrome is associated with long-COVID in women
DR. MATT COOK
Long COVID: 'Viral reservoir' of spike protein may explain long-term symptoms
DR. SUZANNE
GAZDA
Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia
COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study
Incidence, co-occurrence, and evolution of longCOVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19
Long-term neurologic outcomes of COVID-19
Evolution of neurologic symptoms in non-hospitalized COVID-19 "long haulers"
NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection
Microvascular Injury in the Brains of Patients with Covid-19
DR. SUZANNE GAZDA
SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation
The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech)
Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA
Vaccines
Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae
Neuroinflammation: the devil is in the details
COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis
Additional Resources Available HERE
CONTINUED
GEZ MEDINGER
SARS-CoV-2 infection and persistence in the human body and brain at autopsy
DR. RALF OETTMEIER
Information platform toxicity and diseases
ATSDR’s Substance Priority List
Information regarding endocrine disruptors
DR. LYN PATRICK
PFAS Contamination in the US (Map)
Modifiable contributing factors to COVID-19: A comprehensive review
The under-reported role of toxic substance exposures in the COVID-19 pandemic
COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence
DR. LYN PATRICK
CONTINUED
Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis
Excess of COVID-19 cases and deaths due to fine particulate matter exposure during the 2020 wildfires in the United States
SARS-CoV-2 infection, COVID-19 pathogenesis, and exposure to air pollution: What is the connection?
Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?
Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms
Severity of COVID-19 at elevated exposure to perfluorinated alkylates
The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity
Manmade Electromagnetic Fields and Oxidative Stress-Biological Effects and Consequences for Health
Common contributing factors to COVID-19 and inflammatory bowel disease
DR. LYN PATRICK
CONTINUED
Improvement of several stress response and sleep quality hormones in men and women after sleeping in a bed that protects against electromagnetic fields
The use of a bed with an insulating system of electromagnetic fields improves immune function, redox and inflammatory states, and decrease the rate of aging
The Biological Effects of Compound Microwave Exposure with 2.8 GHz and 9.3 GHz on Immune System: Transcriptomic and Proteomic Analysis
Electromagnetic hypersensitivity (EHS, microwave syndrome) - Review of mechanisms
Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19
DR. MOBEEN SYED
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
SARS-CoV-2 is associated with changes in brain structure in UK Biobank
DR. MOBEEN SYED
Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech)
Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
DR. MICHAEL PELUSO
Long-term Impact of Infection with Novel Coronavirus (LIINC): An Observational Study
Researching COVID to Enhance Recovery
DR. KENT HOLTORF
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application
DR. KELLY HALDERMAN
Treatable metabolic and inflammatory abnormalities in Post COVID Syndrome (PCS) define the transcriptomic basis for persistent symptoms: Lessons from CIRS